BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/19/2025 8:32:40 AM | Browse: 73 | Download: 249
 |
Received |
|
2025-05-21 06:21 |
|
Peer-Review Started |
|
2025-05-22 02:54 |
|
First Decision by Editorial Office Director |
|
2025-06-07 02:10 |
|
Return for Revision |
|
2025-06-07 02:10 |
|
Revised |
|
2025-06-11 15:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-10 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-11 03:49 |
|
Articles in Press |
|
2025-10-11 03:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-28 09:30 |
|
Publish the Manuscript Online |
|
2025-12-19 08:32 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Dual incretin analogue tirzepitide - SURMOUNTing the challenge of obesity induced obstructive sleep apnea
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jyoti Bajpai, Mehul Saxena, Utkarsh Agarwal and Akshyaya Pradhan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Akshyaya Pradhan, Department of Cardiology, King George’s Medical University, Shahmina Road, Chowk, Lucknow 226003, Uttar Pradesh, India. akshyaya33@gmail.com |
| Key Words |
Apnea hypopnea index; Weight loss; Continuous positive airway pressure; Glucagon like receptor -1; SURMOUNT-1 trial |
| Core Tip |
Obstructive sleep apnea (OSA) is a serious sleep disorder often caused by obesity. Standard treatments like continuous positive airway pressure can help, but many people struggle to use them long term. Tirzepatide, a new medication that targets both glucagon-like peptide-1 and gastric inhibitory polypeptide receptors, offers a different approach. By helping with significant weight loss and improving breathing during sleep, tirzepatide has shown strong results in the SURMOUNT-OSA trial, making it the first approved drug to directly treat obesity-related OSA. |
| Publish Date |
2025-12-19 08:32 |
| Citation |
Bajpai J, Saxena M, Agarwal U, Pradhan A. Dual incretin analogue tirzepitide - SURMOUNTing the challenge of obesity induced obstructive sleep apnea. World J Exp Med 2025; 15(4): 109762 |
| URL |
https://www.wjgnet.com/2220-315x/full/v15/i4/109762.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v15.i4.109762 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
